Real-World Management of Chronic Myelogenous Leukemia in an Underserved Patient Cohort at a Los Angeles Safety-Net Health System: Tyrosine Kinase Inhibitor Treatment Patterns and Outcomes From 2015 to 2024

By afschroeder • September 17, 2026

Zheng D, Nold T, Ramakrishnan N, Kim K, Tomassetti S. Real-World Management of Chronic Myelogenous Leukemia in an Underserved Patient Cohort at a Los Angeles Safety-Net Health System: Tyrosine Kinase Inhibitor Treatment Patterns and Outcomes From 2015 to 2024. Cancer Med. 2026 Sep;15(9):e72223. doi: 10.1002/cam4.72223. PMID: 42745440.

Tags: chronic myelogenous leukemia, county, Fellow, General Internal Medicine, Harbor UCLA, Hematology/Oncology, Hispanic, Publications, Resident, safety‐net, underserved

Extreme weather events and mental health impacts in West Africa: A systematic review of evidence gaps

Nwanaji-Enwerem JC, Perez-Cruet JM, Sprague N, Uong S, Obi C, Peterson S, Mustapha A, Tiako MJN, Hassan S, Hang Y, Oluseyi T, Mason LR, Ekenga[...]

Kinetics of local C3 production orchestrates neutrophil recruitment in lung injury

Alburquerque RA, Hernandez JI, Nallapu A, Starick M, Hyun J, Sanchez JM, Etesami N, Mukherjee SK, Ozanturk AN, Vazquez J, Chang A, Zheng A, Garnica[...]

Multifactorial causes of severe persistent hypercalcemia in an immunosuppressed woman with chronic kidney disease

Nalluri K, Goodman EL, Pasupneti T, Nunez G, Wang EC. Multifactorial causes of severe persistent hypercalcemia in an immunosuppressed woman with chronic kidney disease. JCEM[...]